The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Historic low how low maybe 22 or 26!
How long it’s go to 4 or 3 now 5 let see
this year will be a lot of merger and a. or takeover in sector look to OCI maybe .. sector will reshape with all players in the market ...
Step by step look to gilaed they increase in to Galapagos 25 procent of the company now so ... they have big funds ..in hand now with Galapagos... so let see the next weeks. ... Sierra update this week on 8 November let see ...
Step by step. Amgen buy 20 procent from beigene Nice some action in pharma .. let see Sar we are now already November ... Let see the big US pharma They are very active these days in the market .., Sar is on level back 2015. ... buy and hold at this level ...let see the next AGM. Only few weeks left ... time fly .. I hope to see some transformation...
step by step .. i think Galapagos and Gilaed are very good company and they have the fund i hope that will take sareum in... imho .. and let see tomorrow the SAR update .. and let see sierra ... the next weeks .... update on 8 nov.
step by step ,, let see next week start Q4 .. i hope gilaed or galapagos are the right companies or us big pharma .. for tyk2 .. let see .. we are the only one left in the market .. with assets in this particular class … now is the time for sareum to transform or ….